Benign Myoclonic Epilepsy In Infancy: Disease Bioinformatics
Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Benign myoclonic epilepsy in infancy is a very rare form of epilepsy, in which infants between four months and three years of age show symptoms of head nodding and loss of balance. This form of epilepsy occurs more in boys than girls, and one-third of the children with this condition have another family member who has epilepsy or suffers from seizures. Benign myoclonic epilepsy is the earliest form of idiopathic generalized epilepsy. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases may require surgery in order to relieve symptoms.
Benign Myoclonic Epilepsy In Infancy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Benign Myoclonic Epilepsy In Infancy below!
For more information on how to use Laverne, please read the How to Guide.
We have 62 products for the study of Benign Myoclonic Epilepsy In Infancy that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.